Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne
Indiana University Health Arnett Cancer Center ( Site 0076), Lafayette

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Community Health Network, Inc, Indianapolis
Community Health Network, Inc., Indianapolis
Community Health Network, Inc., Indianapolis

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07222566

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Franciscan Health, Munster

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07154290

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
Indiana University Health University Hospital, Indianapolis

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Community Health Network, Indianapolis

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

UChicago Medicine Northwest Indiana, Crown Point

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06287775

Increasing Equity in Lung Cancer Screening

Eskenazi Health, Indianapolis

Се регрутираДобредојдени се здрави волонтери

Возраст од 50 до 80 · Сите полови · Ажурирано 10.9.2026 · NCT06360822

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Franciscan Health, Indianapolis
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 1.9.2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Northwest Cancer Center - Crown Point, Crown Point
Northwest Oncology LLC, Dyer
Northwest Cancer Center - Hobart, Hobart
и уште 4

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05624996

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Roudebush VA Medical Center, Indianapolis
Sidney and Lois Eskenazi Hospital, Indianapolis

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 14.7.2026 · NCT05889546

Integrated Cancer Repository for Cancer Research

Parkview Research Center, Fort Wayne

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст од 19 до 110 · Сите полови · Ажурирано 29.6.2026 · NCT02012699

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

University of Indiana, Indianapolis

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 14.5.2026 · NCT06922591

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 5.5.2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis

Се регрутираФаза 2

18 Minutes · Сите полови · Ажурирано 5.5.2026 · NCT06031688

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 8.4.2026 · NCT04919382

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Northwest Cancer Centers, Dyer

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 18.3.2026 · NCT06244771

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 19.2.2026 · NCT02984761

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Baptist Floyd, New Albany

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст 40 и постари · Сите полови · Ажурирано 20.1.2026 · NCT05366881

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.